Μπούτσης Δημήτριος

• Πτυχίο Ιατρκής ΑΠΘ (1995)

• Αιματολογία, Λαϊκό Νοσοκομείο Αθηνών (2004)

• Imperial College-Hammersmith Hospital (2008-2010)

• Αγγλικά
• Γαλλικά
• Γερμανικά

1. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Korovesis K, Mavrogianni D,Boutsis D, Variami E, Viniou N, Konstantopoulos K, Loukopoulos D.Hematol J. 2001;2(1):33-7.

2. Vassilakopoulos T., Angelopoulou M., Siakantaris M., Kontopidou F., Dimopoulou M., Boutsis D., Anargyrou K., Kokoris S., Giannakakis A., Karkantaris C., Kyrtsonis M., Tsaftaridis P., Rombos J., Variamis E., Korkolopoulou P., Kittas C., Pangalis G.A. “Hodgkin’s lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy”. Eur J Haematol 68(5):289-298, 2002.

3. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.Anargyrou K, Paterakis G,Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M, Vassiliadis J, Androulakis A, Meletis J, Rombos J, Tassiopoulou A, Vaiopoulos G.Eur J Haematol. 2003 Oct;71(4):294-8.

4. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin’s lymphoma.Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Karkantaris C, Anargyrou K,Boutsis DE, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA.Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):765-81

5. Acute abdomen as initial manifestation of M4 – acute non-lymphocytic leukemia.Papalambros E, Felekouras E, Karavokyros IG, Diamantis T, Androulaki A,Boutsis D, Sigala F, Tsavaris N, Pangalis G.J BUON. 2005 Apr-Jun;10(2):277-80.

6. New oral anticoagulants: should they replace heparins and warfarin?Tsiara S, Pappas K,Boutsis D, Laffan M.Hellenic J Cardiol. 2011 Jan-Feb;52(1):52-67. Review.

7. Bilateral metachronous testicular chloroma: a rare clinical entity.Dellis A,Boutsis D, Spyropoulos E, Galanakis I, Panagopoulos A, Papatsoris A. Nephrourol Mon. 2013 Nov;5(5):992-3

8. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z, Kourti G, Prassopoulos V, Leonidopoulou T, Terpos E, Dimopoulou MN, Sachanas S, Kalpadakis C, Konstantinidou P,Boutsis D, Stefanoudaki E, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Variami E, Kotsianidis I, Symeonidis A, Michali E, Katodritou E, Kokkini G, Tsatalas C, Papadaki H, Dimopoulos MA, Sotiropoulos V, Pappa V, Karmiris T, Meletis J, Apostolidis J, Datseris I, Panayiotidis P, Konstantopoulos K, Roussou P, Rondogianni P.Leukemia. 2016 Jan;30(1):238-42.

1. Vassilakopoulos T., Angelopoulou M., Siakantaris M., Dimopoulou M., Korkolopoulou P., Kontopidou F., Karkantaris C., Kokoris S., Giannakakis A., Barbounis A., Konstantopoulos K., Variamis E.,Rombos J.,Anargyrou K., Boutsis D.,Boussiotis V.A., Fessas Ph., Kittas C., Pangalis G.A. “ Prediction of bone marrow involvement on the basis of the clinical and laboratory characteristics of patients with Hodgkin’s lymphoma”. 8^th International Conference on Malignant Lymphoma, Lugano, Switzerland, 12-15 June, 2002.
2. Vassilakopoulos T., Angelopoulou M., Siakantaris M., Dimopoulou M., Korkolopoulou P., Kontopidou F., Karkantaris C., Kokoris ., Giannakakis A., Barbounis A., Konstantopoulos K.,Variamis E.,Rombos J., Anargyrou K., Boutsis D., Boussiotis V.A. Fessas Ph., Kittas C., Pangalis G.A. “Prediction of bone marrow involvement on the basis of the clinical and laboratory characteristics of patients with Hodgkin’s lymphoma”. 7^th meeting of the EHA, Florence, Italy, 6-9 June, 2002.
3. Kalotychou V., Janetea P., Boutsis D., Rombos J. “The cytoprotective role of amifostine to the normal stem cells against the toxicity of idarubicin”. 12^th Greek Haematology Conference, Athens, 22-24 November, 2001.
4. Politou M., Stamatopoulos K., Boutsis D., Komninaka V., Dimopoulou M., Viniou N., Plata E., Variamis E., Rombos J., Konstantopoulos K., Giataganas X. “Early experience of STI 571 use in patients with CML”. 12^th Greek Haematology Conference, Athens 22-24 November, 2001.
5. Rombos J., Boutsis D., Kalotychou V., Tsekoura C., Siakantaris M., Nodaros K., Anargyrou K., Poziopoulos C., Dimopoulou M., Vassilakopoulos T., Politou M., Variamis E., Pangalis G.A., Loukopoulos D. “Autologous Bone Marrow Transplantation in Lymphoma”. 12^th Greek Haematology Conference, Athens 22-24 November, 2001.

• Advanced Trauma Life Support (A.T.L.S), September 24-25, 1999, National and Kapodistrian University of Athens, Medical School.
• 3^rd Euroconference on Blood and Marrow Transplantation, November 3-7, 2001, Athens, Greece.
• 7^th ESH – EBMT Training Course on Blood and Marrow Transplantation, May 9-12, 2003, Cascais, Portugal.
• 11^th Congress of the EHA, June 15-18, 2006, Amsterdam, The Nederlands.
• Lymphoma Forum of Excellence (LyFE) Programme, September 21-22, 2006, Cologne, Germany.
• 3^rd European Congress of Haematologic Malignacies, February 23-25, 2007, Athens, Greece.
• 12^th Congress of the EHA, June 7-10, 2007, Vienna, Austria.
• 18^th Congress of the EHA, June 13-16, 2013, Stockholm, Sweden.

Τμήμα

Τμήμα Αιματολογικών Νοσημάτων

Επικοινωνία

Ευρωκλινική Αθηνών

Αθανασιάδου 7-9,  Αθήνα, ΤΚ 115 21

Τηλέφωνο: 210 6416600

Τηλέφωνο για ραντεβού: 210 6416600

Φαξ: 210 6416555